EC Healthcare
UNHLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.64 | -1.67 | -2.30 |
| FCF Yield | 44.90% | 34.35% | 2.58% | 7.27% |
| EV / EBITDA | 3.02 | 3.48 | 10.70 | 6.05 |
| Quality | ||||
| ROIC | 2.71% | 2.34% | 4.06% | 8.01% |
| Gross Margin | 80.73% | 84.18% | 85.73% | 88.03% |
| Cash Conversion Ratio | -7.35 | -36.37 | 8.73 | 1.89 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.23% | 12.99% | 23.04% | 14.43% |
| Free Cash Flow Growth | 29.97% | 169.56% | -43.74% | -26.21% |
| Safety | ||||
| Net Debt / EBITDA | 0.55 | 1.41 | 1.05 | 0.09 |
| Interest Coverage | 1.06 | 1.08 | 3.44 | 7.42 |
| Efficiency | ||||
| Inventory Turnover | 5.23 | 6.22 | 6.36 | 3.46 |
| Cash Conversion Cycle | 57.80 | 41.93 | 11.09 | 27.04 |